Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis.

Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis. Thromb Haemost. 2021 08; 121(8):1079-1086.

View in: PubMed

subject areas

Adolescent
Adult
Child
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Coagulants
Drug Administration Schedule
Drug Substitution
Factor VIII
Hemarthrosis
Hemophilia A
Hemorrhage
Humans
Male
Middle Aged
Polyethylene Glycols
Randomized Controlled Trials as Topic
Retrospective Studies
Time Factors
Treatment Outcome
Young Adult

authors with profiles

Mindy Simpson